Intravenous Tranexamic Acid Given at Femoral Fragility Fracture Surgery Reduces Blood Transfusion Requirements Fourfold

AIMS: This study aims to determine whether intraoperative intravenous (IV) tranexamic acid (TXA) affects blood loss following the surgical management of femoral fragility fractures (FFF). METHODS: This was a single centre (university teaching hospital) non-randomised case–control study. There were 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Powell-Bowns, Matilda F. R., Olley, Rhys K., McCann, Conor, Balfour, James R., Brennan, Caitlin M., Peh, Jasmine, Duckworth, Andrew D., Scott, Chloe E. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Scientific Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971041/
https://www.ncbi.nlm.nih.gov/pubmed/36725742
http://dx.doi.org/10.1007/s00268-022-06886-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971041/
https://www.ncbi.nlm.nih.gov/pubmed/36725742
http://dx.doi.org/10.1007/s00268-022-06886-2

Ejemplares similares